Dan Leonard analyst

Currently out of the existing stock ratings of Dan Leonard, 84 are a HOLD (32.94%), 156 are a BUY (61.18%), 15 are a SELL (5.88%).

Dan Leonard

Work Performance Price Targets & Ratings Chart

Analyst Dan Leonard, currently employed carries an average stock price target met ratio of 70.88% that have a potential upside of 15.31% achieved within 182 days. Previously, Dan Leonard worked at WELLS FARGO.

Dan Leonard’s has documented 527 price targets and ratings displayed on 33 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on CERT, Certara at 01-Mar-2024.

Wall Street Analyst Dan Leonard

Analyst best performing recommendations are on STVN (STEVANATO GROUP SPA).
The best stock recommendation documented was for LMNX (LUMINEX) at 5/7/2018. The price target of $22 was fulfilled within 1 day with a profit of $0.64 (3%) receiving and performance score of 29.96.

Average potential price target upside

A Agilent Technologies AVTR Avantor BIO Bio-Rad Laboratories BRKR Bruker DHR Danaher EXAS EXACT Sciences GH Guardant Health HOLX Hologic ILMN Illumina IQV IQVIA Holdings MTD Mettler-Toledo International MYGN Myriad Genetics NTRA Natera NVTA Invitae Corp PKI PerkinElmer TECH Bio-Techne Corp TMO Thermo Fisher Scientific LH Laboratory of America Holdings WAT Waters CRL Charles River Laboratories DGX Quest Diagnostics orporated FLDM Fluidigm ICLR ICON PLC QGEN Qiagen NV CERT Certara FLGT Fulgent Genetics MRVI Maravai Lifesciences Holdings  STVN Stevanato Group SpA ADPT Adaptive Biotechnologies Corp PROG Progenity LMNX Luminex RHP Ryman Hospitality Properties GHDX Genomic Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$145

$8.13 (5.94%)

$135

21 days ago
(15-Oct-2024)

5/9 (55.56%)

$0.42 (0.29%)

99

$145

$8.13 (5.94%)

$135

1 months 4 days ago
(01-Oct-2024)

4/4 (100%)

$-1.56 (-1.06%)

17

Hold

$147

$10.13 (7.40%)

$140

2 months 14 days ago
(22-Aug-2024)

6/6 (100%)

$6.78 (4.84%)

92

Buy

$200

4 months 9 days ago
(27-Jun-2024)

8/9 (88.89%)

$28.88 (16.88%)

196

Buy

$135

$-1.87 (-1.37%)

$146

5 months 2 days ago
(03-Jun-2024)

13/15 (86.67%)

$3.6 (2.74%)

403

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Dan Leonard?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?